Resumen

REBELO, Isabel; MAURICIO, Sandra; COELHO, David  y  GASPAR, Ana. Anesthetic management of carcinoid syndrome: is octreotide enough? A case report. Rev. mex. anestesiol. [online]. 2019, vol.42, n.2, pp.133-136.  Epub 30-Mar-2020. ISSN 0484-7903.

Carcinoid tumors are rare slow-growing neuroendocrine tissue neoplasms. Their ability to secrete bioactive substances to the systemic circulation is accountable for a clinical presentation known as carcinoid syndrome. Main symptoms include bronchoconstriction, flushing, diarrhea and hemodynamic instability. Octreotide, a somatostatin analogue, is the current mainstay for carcinoid syndrome treatment and perioperative management. However, no regimen has proven to be completely effective in preventing systemic manifestations and recent literature suggests that it might be an insufficient measure. We report a case of a 51-year-old male with a functioning small bowel neuroendocrine tumor and carcinoid syndrome presenting for a primary tumor resection, discussing possible pitfalls and key points in the care of these patients.

Palabras llave : Carcinoid syndrome; neuroendrocrine tumor; anaesthetic management; hemodynamic instability; octreotide.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )